As per the report titled ‘Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) – By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)’, available with Market Study Report, Global Acne Treatment Market was valued at USD 5,124.98 million in the year 2018, and is expected to record remunerative growth over 2019-2024.
 

Increasing pervasiveness of acne due to varying hormone levels, unhealthy lifestyle, bad eating habits, and excessive oil production from sebaceous glands are driving the growth of global acne treatment market. Rising per capita income, widespread adoption of less painful aesthetic therapy procedures, growing enhancements, and existing seamless skincare industry are further enhancing the market scenario. Furthermore, increasing prevalence of habits such as smoking, drinking, consuming fatty foods coupled with increasing consumption of high sugar foods, and high fatty dairy products are bolstering the global acne treatment market size.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2361882/
 

Based on treatment provided, medication treatment segment is anticipated to witness substantial growth during the analysis timeframe due to rising omnipresence of acne vulgaris, high per capita income, and growing young population.
 

Based on regional landscape, North America holds a substantial market share owing to the presence of developed medical infrastructure and increasing number of patients undergoing acne treatment. Additionally, rising healthcare awareness, surging number of hospitals which include various government programs to enhance the treatment of patients, and innovative acne treatment technologies are further propelling the market growth in North America.
 

The key contenders in global acne treatment market are Teva Pharmaceutical Industries Ltd., Novan, Cipher Pharmaceuticals, Bayer AG, Johnson & Johnson, Foamix Pharmaceuticals Inc., Allergan Plc, Bausch Health Companies Inc., Galderma S.A., and GlaxoSmithKline Plc among others.